|
1
|
Clavien PA, Lesurtel M, Bossuyt PM, et al:
Recommendations for liver transplantation for hepatocellular
carcinoma: an international consensus conference report. Lancet
Oncol. 13:e11–e22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schrader J, Gordon-Walker TT, Aucott RL,
et al: Matrix stiffness modulates proliferation, chemotherapeutic
response, and dormancy in hepatocellular carcinoma cells.
Hepatology. 53:1192–1205. 2011. View Article : Google Scholar
|
|
4
|
Osada T, Sakamoto M, Ino Y, et al:
E-cadherin is involved in the intrahepatic metastasis of
hepatocellular carcinoma. Hepatology. 24:1460–1467. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei Y, Van Nhieu JT, Prigent S,
Srivatanakul P, Tiollais P and Buendia MA: Altered expression of
E-cadherin in hepatocellular carcinoma: correlations with genetic
alterations, β-catenin expression, and clinical features.
Hepatology. 36:692–701. 2002.PubMed/NCBI
|
|
6
|
Marsit CJ, Posner MR, McClean MD and
Kelsey KT: Hypermethylation of E-cadherin is an independent
predictor of improved survival in head and neck squamous cell
carcinoma. Cancer. 113:1566–1571. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maeda G, Chiba T, Aoba T and Imai K:
Epigenetic inactivation of E-cadherin by promoter hypermethylation
in oral carcinoma cells. Odontology. 95:24–29. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiao W, Miyazaki K and Kitajima Y: Inverse
correlation between E-cadherin and Snail expression in
hepatocellular carcinoma cell lines in vitro and in vivo. Br J
Cancer. 86:98–101. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Evans AJ, Russell RC, Roche O, et al: VHL
promotes E2 box-dependent E-cadherin transcription by HIF-mediated
regulation of SIP1 and snail. Mol Cell Biol. 27:157–169. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohshima K, Haraoka S, Yoshioka S, et al:
Chromosome 16q deletion and loss of E-cadherin expression in
Hodgkin and Reed-Sternberg cells. Int J Cancer. 92:678–682. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan Y, Matsuyama H, Wang N, et al:
Chromosome 16q24 deletion and decreased E-cadherin expression:
possible association with metastatic potential in prostate cancer.
Prostate. 36:31–38. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu YC, Shen CY, Wu HS, et al: Mechanisms
inactivating the gene for E-cadherin in sporadic gastric
carcinomas. World J Gastroenterol. 12:2168–2173. 2006.PubMed/NCBI
|
|
13
|
Deng Y, Deng H, Liu J, et al:
Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in
breast cancer. Mol Carcinog. 51:500–507. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moreno-Bueno G, Portillo F and Cano A:
Transcriptional regulation of cell polarity in EMT and cancer.
Oncogene. 27:6958–6969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pena C, Garcia JM, Garcia V, et al: The
expression levels of the transcriptional regulators p300 and CtBP
modulate the correlations between SNAIL, ZEB1, E-cadherin and
vitamin D receptor in human colon carcinomas. Int J Cancer.
119:2098–2104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu W, Dong J, Huang Z, Guo D, Liu Y and
Shi S: Comparison of four current staging systems for Chinese
patients with hepatocellular carcinoma undergoing curative
resection: Okuda, CLIP, TNM and CUPI. J Gastroenterol Hepatol.
23:1874–1878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gotte M, Kersting C, Radke I, Kiesel L and
Wulfing P: An expression signature of syndecan-1 (CD138),
E-cadherin and c-met is associated with factors of angiogenesis and
lymphangiogenesis in ductal breast carcinoma in situ. Breast Cancer
Res. 9:R82007. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chinnadurai G: CtBP, an unconventional
transcriptional corepressor in development and oncogenesis. Mol
Cell. 9:213–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schaeper U, Subramanian T, Lim L, Boyd JM
and Chinnadurai G: Interaction between a cellular protein that
binds to the C-terminal region of adenovirus E1A (CtBP) and a novel
cellular protein is disrupted by E1A through a conserved PLDLS
motif. J Biol Chem. 273:8549–8552. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao LJ, Subramanian T, Vijayalingam S and
Chinnadurai G: PLDLS-dependent interaction of E1A with CtBP:
regulation of CtBP nuclear localization and transcriptional
functions. Oncogene. 26:7544–7551. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Frisch SM: Antioncogenic effect of
adenovirus E1A in human tumor cells. Proc Natl Acad Sci USA.
88:9077–9081. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frisch SM: Tumor suppression activity of
adenovirus E1a protein: anoikis and the epithelial phenotype. Adv
Cancer Res. 80:39–49. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grooteclaes ML and Frisch SM: Evidence for
a function of CtBP in epithelial gene regulation and anoikis.
Oncogene. 19:3823–3828. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kippenberger S, Loitsch S, Thaci D, et al:
Restoration of E-cadherin sensitizes human melanoma cells for
apoptosis. Melanoma Res. 16:393–403. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lowy AM, Knight J and Groden J:
Restoration of E-cadherin/β-catenin expression in pancreatic cancer
cells inhibits growth by induction of apoptosis. Surgery.
132:141–148. 2002.
|
